{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:50:00Z","timestamp":1789753800329,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772198"],"award-info":[{"award-number":["81772198"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10096-023-04566-0","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T03:02:32Z","timestamp":1677553352000},"page":"503-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients"],"prefix":"10.1007","volume":"42","author":[{"given":"Lei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DePeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"4566_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/bjh.17877","volume":"196","author":"V Marasco","year":"2022","unstructured":"Marasco V, Carniti C, Guidetti A, Farina L, Magni M, Miceli R et al (2022) T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies. Br J Haematol 196:548\u2013558","journal-title":"Br J Haematol"},{"key":"4566_CR2","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/23744235.2020.1806353","volume":"52","author":"KTL Sy","year":"2020","unstructured":"Sy KTL, Haw NJL, Uy J (2020) Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond) 52:902\u2013907","journal-title":"Infect Dis (Lond)"},{"key":"4566_CR3","unstructured":"Liu Y, L Bi, Y Chen, Y Wang, M Cheng (2020) Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. medRxiv"},{"key":"4566_CR4","unstructured":"WHO (2021) Global tuberculosis report. Geneva, Switzerland: World Health Organization"},{"key":"4566_CR5","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, C\u00e1rdenas V, Shukarev G, Grinsztejn B et al (2021) Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19. N Engl J Med. 384:2187\u2013201","journal-title":"N Engl J Med."},{"key":"4566_CR6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/jamainternmed.2021.4325","volume":"181","author":"BV John","year":"2021","unstructured":"John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D et al (2021) Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med 181:1306\u20131314","journal-title":"JAMA Intern Med"},{"key":"4566_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa2107058","volume":"385","author":"MG Thompson","year":"2021","unstructured":"Thompson MG, Burgess JL, Naleway AL, Tyner H, Yoon SK, Meece J et al (2021) Prevention and attenuation of COVID-19 with the BNT162b2 and mRNA-1273 vaccines. N Engl J Med 385:320\u2013329","journal-title":"N Engl J Med"},{"key":"4566_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10238-013-0258-1","volume":"14","author":"MT Abreu","year":"2014","unstructured":"Abreu MT, Carvalheiro H, Rodrigues-Sousa T, Domingos A, Segorbe-Luis A, Rodrigues-Santos P et al (2014) Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients. Clin Exp Med 14:423\u2013429","journal-title":"Clin Exp Med"},{"key":"4566_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2020.110016","volume":"221","author":"KP Lyashchenko","year":"2020","unstructured":"Lyashchenko KP, Vordermeier HM, Waters WR (2020) Memory B cells and tuberculosis. Vet Immunol Immunopathol 221:110016","journal-title":"Vet Immunol Immunopathol"},{"key":"4566_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jinf.2021.12.003","volume":"84","author":"WA Mak","year":"2022","unstructured":"Mak WA, Koeleman JGM, van der Vliet M, Keuren F, Ong DSY (2022) SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: a prospective cohort study. J Infect 84:171\u2013178","journal-title":"J Infect"},{"key":"4566_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clim.2015.02.008","volume":"157","author":"CJ Serrano","year":"2015","unstructured":"Serrano CJ, Casta\u00f1eda-Delgado JE, Trujillo-Ochoa JL, Gonz\u00e1lez-Amaro R, Garc\u00eda-Hern\u00e1ndez MH, Enciso-Moreno JA (2015) Regulatory T-cell subsets in response to specific Mycobacterium tuberculosis antigens in vitro distinguish among individuals with different QTF and TST reactivity. Clin Immunol 157:145\u2013155","journal-title":"Clin Immunol"},{"key":"4566_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tube.2018.10.011","volume":"114","author":"AV Dyatlov","year":"2019","unstructured":"Dyatlov AV, Apt AS, Linge IA (2019) B lymphocytes in anti-mycobacterial immune responses: pathogenesis or protection? Tuberculosis (Edinb) 114:1\u20138","journal-title":"Tuberculosis (Edinb)"},{"key":"4566_CR13","first-page":"7","volume":"19","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang Y, Yang Q, Deng G, Chen Qi, Chen W et al (2019) Dynamic changes of T cell and B cell subsets in peripheral blood of tuberculosis patients during treatment. China Trop Med 19:7","journal-title":"China Trop Med"},{"key":"4566_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005687","volume":"12","author":"SA Joosten","year":"2016","unstructured":"Joosten SA, van Meijgaarden KE, Del Nonno F, Baiocchini A, Petrone L, Vanini V et al (2016) Patients with tuberculosis have a dysfunctional circulating B-cell compartment, which normalizes following successful treatment. PLoS Pathog 12:e1005687","journal-title":"PLoS Pathog"},{"key":"4566_CR15","unstructured":"WHO (2019) Global tuberculosis report. Geneva, Switzerland: World Health Organization"},{"key":"4566_CR16","unstructured":"Feng J, Zhang J (2021) Research progress in COVID-19 vaccines. Anti Infect Pharm. 1715\u20131723"},{"key":"4566_CR17","doi-asserted-by":"crossref","unstructured":"Harboe ZB, Hamm SR, P\u00e9rez-Al\u00f3s L, Sivapalan P, Priem\u00e9 H, Wilcke T, et al. (2022) Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases, BMJ Open Respir Res, 9","DOI":"10.1136\/bmjresp-2022-001268"},{"key":"4566_CR18","doi-asserted-by":"publisher","first-page":"eaai8153","DOI":"10.1126\/sciimmunol.aai8153","volume":"2","author":"D Lau","year":"2017","unstructured":"Lau D, Lan LY, Andrews SF, Henry C, Rojas KT, Neu KE et al (2017) Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation. Sci Immunol 2:eaai8153","journal-title":"Sci Immunol"},{"key":"4566_CR19","doi-asserted-by":"crossref","unstructured":"Sosa-Hern\u00e1ndez VA, Torres-Ru\u00edz J, Cervantes-D\u00edaz R, Romero-Ram\u00edrez S, P\u00e1ez-Franco JC, Meza-S\u00e1nchez DE, et al. (2020) B cell subsets as severity-associated signatures in COVID-19 patients. Front Immunol; 11","DOI":"10.3389\/fimmu.2020.611004"},{"key":"4566_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.chom.2022.01.003","volume":"30","author":"S Terreri","year":"2022","unstructured":"Terreri S, Piano Mortari E, Vinci MR, Russo C, Alteri C, Albano C et al (2022) Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections. Cell Host Microbe 30:400-408.e4","journal-title":"Cell Host Microbe"},{"key":"4566_CR21","doi-asserted-by":"crossref","unstructured":"Wang CY, Hwang KP, Kuo HK, Peng WJ, Shen YH, Kuo BS, et al. (2022) A multitope SARS\u2013CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. J Clin Invest; 132","DOI":"10.1172\/JCI157707"},{"key":"4566_CR22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41423-020-00542-2","volume":"17","author":"B Oliviero","year":"2020","unstructured":"Oliviero B, Varchetta S, Mele D, Mantovani S, Cerino A, Perotti CG et al (2020) Expansion of atypical memory B cells is a prominent feature of COVID-19. Cell Mol Immunol 17:1101\u20131103","journal-title":"Cell Mol Immunol"},{"key":"4566_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/JLB.5COVA0620-370RR","volume":"109","author":"NH Wildner","year":"2021","unstructured":"Wildner NH, Ahmadi P, Schulte S, Brauneck F, Kohsar M, L\u00fctgehetmann M et al (2021) B cell analysis in SARS-CoV-2 versus malaria: increased frequencies of plasmablasts and atypical memory B cells in COVID-19. J Leukoc Biol 109:77\u201390","journal-title":"J Leukoc Biol"},{"key":"4566_CR24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1080\/22221751.2022.2059401","volume":"11","author":"L Ao","year":"2022","unstructured":"Ao L, Lu T, Cao Y, Chen Z, Wang Y, Li Z et al (2022) Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV. Emerg Microbes Infect 11:1126\u20131134","journal-title":"Emerg Microbes Infect"},{"key":"4566_CR25","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","volume":"383","author":"EE Walsh","year":"2020","unstructured":"Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A et al (2020) Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates. N Engl J Med 383:2439\u20132450","journal-title":"N Engl J Med"},{"key":"4566_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812126","volume":"13","author":"GX Medeiros","year":"2022","unstructured":"Medeiros GX, Sasahara GL, Magawa JY, Nunes JPS, Bruno FR, Kuramoto AC et al (2022) Reduced T cell and antibody responses to inactivated coronavirus vaccine among individuals above 55 years old. Front Immunol 13:812126","journal-title":"Front Immunol"},{"key":"4566_CR27","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","volume":"383","author":"EJ Anderson","year":"2020","unstructured":"Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M et al (2020) Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 383:2427\u20132438","journal-title":"N Engl J Med"},{"key":"4566_CR28","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","volume":"396","author":"MN Ramasamy","year":"2021","unstructured":"Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR et al (2021) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial. Lancet 396:1979\u20131993","journal-title":"Lancet"},{"key":"4566_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ckj\/sfab206","volume":"15","author":"A Angel-Korman","year":"2022","unstructured":"Angel-Korman A, Peres E, Bryk G, Lustig Y, Indenbaum V, Amit S et al (2022) Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose. Clin Kidney J 15:226\u2013234","journal-title":"Clin Kidney J"},{"key":"4566_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","volume":"27","author":"KJ Ewer","year":"2021","unstructured":"Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R et al (2021) T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial. Nat Med 27:270\u2013278","journal-title":"Nat Med"},{"key":"4566_CR31","doi-asserted-by":"crossref","unstructured":"Wang P, Yang N, Xue Y, Zhou J, Wu Y, Wang T, et al. (2022) The fluctuation trend of serum anti-SARS-CoV-2 IgM\/IgG antibodies seroprevalence in the non-COVID-19 infected population and correlation with peripheral blood leukocyte parameters in Beijing, China, 2021: a real-world study. Vaccines (Basel). 10","DOI":"10.3390\/vaccines10040571"},{"key":"4566_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejca.2022.03.013","volume":"168","author":"O Margalit","year":"2022","unstructured":"Margalit O, Shacham-Shmueli E, Itay A, Berger R, Halperin S, Jurkowicz M et al (2022) Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours. Eur J Cancer 168:51\u201355","journal-title":"Eur J Cancer"},{"key":"4566_CR33","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1016\/S2666-5247(21)00305-0","volume":"3","author":"B Barin","year":"2022","unstructured":"Barin B, Kasap U, Sel\u00e7uk F, Volkan E, Ulu\u00e7kan \u00d6 (2022) Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study. Lancet Microbe 3:e274\u2013e283","journal-title":"Lancet Microbe"},{"key":"4566_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006307","volume":"4","author":"T Thye","year":"2009","unstructured":"Thye T, Scarisbrick G, Browne EN, Chinbuah MA, Gyapong J, Osei I et al (2009) CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population. PLoS ONE 4:e6307","journal-title":"PLoS ONE"},{"key":"4566_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.0105-2896.2006.00419.x","volume":"212","author":"DM Sansom","year":"2006","unstructured":"Sansom DM, Walker LS (2006) The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212:131\u2013148","journal-title":"Immunol Rev"},{"key":"4566_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/sji.12511","volume":"85","author":"SL Feruglio","year":"2017","unstructured":"Feruglio SL, Kvale D, Dyrhol-Riise AM (2017) T cell responses and regulation and the impact of in vitro IL-10 and TGF-\u03b2 modulation during treatment of active tuberculosis. Scand J Immunol 85:138\u2013146","journal-title":"Scand J Immunol"},{"key":"4566_CR37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1086\/511277","volume":"195","author":"T Roberts","year":"2007","unstructured":"Roberts T, Beyers N, Aguirre A, Walzl G (2007) Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta, and interleukin-4 mRNA levels. J Infect Dis 195:870\u2013878","journal-title":"J Infect Dis"},{"key":"4566_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.846753","volume":"13","author":"C Farroni","year":"2022","unstructured":"Farroni C, Picchianti-Diamanti A, Aiello A, Nicastri E, Lagan\u00e0 B, Agrati C et al (2022) Kinetics of the B- and T-cell immune responses after 6 months from SARS-CoV-2 mRNA vaccination in patients with rheumatoid arthritis. Front Immunol 13:846753","journal-title":"Front Immunol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04566-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T19:09:16Z","timestamp":1679857756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04566-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["4566"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04566-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"10 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University and conformed with the ethical guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement for human and\/or animal studies"}},{"value":"Written informed consent was obtained from all participants prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}